The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis
Open accessAbstract
AIMS: High-throughput metabolite quantification holds promise for cardiovascular risk assessment. Here, we evaluated whether metabolite quantification by nuclear magnetic resonance (NMR) improves prediction of subclinical atherosclerosis in comparison to conventional lipid testing. METHODS AND RESULTS: Circulating lipids, lipoprotein subclasses, and small molecules were assayed by NMR for 1595 individuals aged 24-39 years from the population-based Cardiovascular Risk in Young Finns Study. Carotid intima-media thickness (IMT), a marker of subclinical atherosclerosis, was measured in 2001 and 2007. Baseline conventional risk factors and systemic metabolites were used to predict 6-year incidence of high IMT (≥ 90 th percentile) or plaque. The best prediction of high intima-media thickness was achieved when total and HDL cholesterol were replaced by NMR-determined LDL cholesterol and medium HDL, docosahexaenoic acid, and tyrosine in prediction models with risk factors from the Framingham risk score. The extended prediction model improved risk stratification beyond established risk factors alone; area under the receiver operating characteristic curve 0.764 vs. 0.737, P =0.02, and net reclassification index 17.6%, P =0.0008. Higher docosahexaenoic acid levels were associated with decreased risk for incident high IMT (odds ratio: 0.74; 95% confidence interval: 0.67-0.98; P = 0.007). Tyrosine (1.33; 1.10-1.60; P = 0.003) and glutamine (1.38; 1.13-1.68; P = 0.001) levels were associated with 6-year incident high IMT independent of lipid measures. Furthermore, these amino acids were cross-sectionally associated with carotid IMT and the presence of angiographically ascertained coronary artery disease in independent populations. CONCLUSION: High-throughput metabolite quantification, with new systemic biomarkers, improved risk stratification for subclinical atherosclerosis in comparison to conventional lipids and could potentially be useful for early cardiovascular risk assessment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · cited 2×
“Integrated discrimination index represents a continuous variant of NRI and is defined as the difference in mean discrimination slopes between two models.(24) Risk prediction models were evaluated using 10-fold cross-validation so that prediction of an individual’s risk was not influenced by his or her own outcome stat…”
MethodGut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 1×
“In this respect, the wider metabolite coverage achieved by mass spectrometry holds further promise both for risk assessment and discovery of pathways linked to CVD processes.(40,41) On the other hand, NMR compares favourably to mass spectrometry in terms of ease of sample preparation, automation, reproducibility, and…”
BackgroundFish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143 · cited 3×
“Tyrosine was recently linked with the risk for the development of type 2 diabetes; however, the pathogenic mechanism behind this association remains elusive.(5) Glutamine is the most abundant amino acid in blood and an important precursor of glucose during fast.”
BackgroundMethodLorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M., & Sitzer, M. (2007) · Circulation · doi:10.1161/circulationaha.106.628875 · Cited by 2,977
Raitakari, O. T., Juonala, M., Kähönen, M., Taittonen, L., Laitinen, T., Mäki-Torkko, N., Järvisalo, M. J., Uhari, M., Jokinen, E., Rönnemaa, T., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2277 · Cited by 1,732
Self-citationCardiovascular Risk Prediction: Basic Concepts, Current Status, and Future Directions
Lloyd-Jones, D. M. (2010) · Circulation · doi:10.1161/circulationaha.109.849166 · Cited by 705 · cited 2×
“The extended prediction model displayed superior global fit than the reference model (log-likelihood ratio x(2) 1⁄4 30) and lower Akaike Information Criterion, supporting the conclusion that the extended model yields improved risk prediction.(25) Calibration was similar for the two models as evident from the HL statis…”
ResultMora, S., Otvos, J. D., Rifai, N., Rosenson, R. S., Buring, J. E., & Ridker, P. M. (2009) · Circulation · doi:10.1161/circulationaha.108.816181 · Cited by 490
Cited by
Soininen, P., Kangas, A. J., Würtz, P., Suna, T., & Ala-Korpela, M. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000216 · Cited by 900
Self-citationMendelian randomization of blood lipids for coronary heart disease
Holmes, M. V., Asselbergs, F. W., Palmer, T. M., Drenos, F., Lanktree, M. B., Nelson, C. P., Dale, C. E., Padmanabhan, S., Finan, C., Swerdlow, D. I., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/eht571 · Cited by 748
Würtz, P., Havulinna, A. S., Soininen, P., Tynkkynen, T., Prieto-Merino, D., Tillin, T., Ghorbani, A., Artati, A., Wang, Q., Tiainen, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013116 · Cited by 677
Self-citationBranched-Chain and Aromatic Amino Acids Are Predictors of Insulin Resistance in Young Adults
Würtz, P., Soininen, P., Kangas, A. J., Rönnemaa, T., Lehtimäki, T., Kähönen, M., Viikari, J. S., Raitakari, O. T., & Ala-Korpela, M. (2013) · Diabetes Care · doi:10.2337/dc12-0895 · Cited by 548
Self-citationA metabolic view on menopause and ageing
Auro, K., Joensuu, A., Fischer, K., Kettunen, J., Salo, P., Mattsson, H., Niironen, M., Kaprio, J., Eriksson, J. G., Lehtimäki, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms5708 · Cited by 270
Self-citationThe interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Finney, A. C., Das, S., Kumar, D., McKinney, M. P., Cai, B., Yurdagul, A., & Rom, O. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1116861 · Cited by 40
History and future of omega-3 fatty acids in cardiovascular disease
Sperling, L. S., & Nelson, J. R. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1120190 · Cited by 34
von Eckardstein, A., & Rohrer, L. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000294 · Cited by 33
Metadata
- Authors
- Wurtz, P., Raiko, J. R., Magnussen, C. G., Soininen, P., Kangas, A. J., Tynkkynen, T., Thomson, R., Laatikainen, R., Savolainen, M. J., Laurikka, J., Kuukasjarvi, P., Tarkka, M., Karhunen, P. J., Jula, A., Viikari, J. S., Kahonen, M., Lehtimaki, T., Juonala, M., Ala-Korpela, M., & Raitakari, O. T.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-26
- Volume
- 33
- Issue
- 18
- Pages
- 2307-2316
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2219267274
- Cited by
- 158
- References
- 13
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.